EUVIMEDEUVIMED entdecken
Crossref

Prognostic Significance of Plasma Soluble IL-6 Receptor in Carbon-ion Radiotherapy for Pancreatic Cancer

Kazutaka Doi, Makoto Shinoto, Tetsuro Isozaki, Takashi Imai, Toshiki Aiba, Sumitaka Hasegawa, Tsuguhide Takeshima

Anticancer Research · 2025

DOI: 10.21873/anticanres.17406 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Kazutaka Doi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Regulatory Science Research, National Institutes for Quantum Science and Technology, Chiba, Japan. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Receptors, Interleukin-6, Heavy Ion Radiotherapy, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsReceptors, Interleukin-6Heavy Ion RadiotherapyBiomarkers, TumorHumansMaleFemalePrognosisAgedMiddle AgedNeoplasm Recurrence, LocalAged, 80 and overAdult

Stichwörter der Autor:innen

Pancreatic cancercarbon-ion radiation therapysoluble IL-6 receptor

Substanzen

Receptors, Interleukin-6Biomarkers, TumorIL6R protein, human

Autor:innen und Institutionen

  • Department of Radiation Regulatory Science Research, National Institutes for Quantum Science and Technology, Chiba, Japan.
  • QST hospital, National Institutes for Quantum Science and Technology, Chiba, Japan.
  • Medical Data Bank, National Institutes for Quantum Science and Technology, Chiba, Japan.
  • Department of Charged Particle Therapy Research, National Institutes for Quantum Science and Technology, Chiba, Japan.
  • Department of Charged Particle Therapy Research, National Institutes for Quantum Science and Technology, Chiba, Japan takeshima.tsuguhide@qst.go.jp.

Zitieren

APA

Doi, K., Shinoto, M., Isozaki, T., Imai, T., Aiba, T., Hasegawa, S., & Takeshima, T. (2025). Prognostic Significance of Plasma Soluble IL-6 Receptor in Carbon-ion Radiotherapy for Pancreatic Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.17406

Vancouver

Doi K, Shinoto M, Isozaki T, Imai T, Aiba T, Hasegawa S, et al. Prognostic Significance of Plasma Soluble IL-6 Receptor in Carbon-ion Radiotherapy for Pancreatic Cancer. Anticancer Research. 2025. doi:10.21873/anticanres.17406

BibTeX
@article{Doi2025,
  author = {Doi, Kazutaka and Shinoto, Makoto and Isozaki, Tetsuro and Imai, Takashi and Aiba, Toshiki and Hasegawa, Sumitaka and Takeshima, Tsuguhide},
  title = {Prognostic Significance of Plasma Soluble IL-6 Receptor in Carbon-ion Radiotherapy for Pancreatic Cancer},
  journal = {Anticancer Research},
  year = {2025},
  doi = {10.21873/anticanres.17406}
}
Kostenlos starten →